Reply

Authors

  • Anitta Ruuskanen Department of Neurology, Päijät-Häme Joint Authority for Health and Wellbeing, Finland
  • Katri Kaukinen Department of Internal Medicine, Tampere 359 University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland

DOI:

https://doi.org/10.15403/jgld-4568

Keywords:

ageing, comorbidities, antigliadin antibodies

Downloads

Published

2022-09-16

How to Cite

1.
Ruuskanen A, Kaukinen K. Reply. JGLD [Internet]. 2022 Sep. 16 [cited 2025 Jul. 15];31(3):358-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/4568

Issue

Vol. 31 No. 3: September 2022

Section

Letters